ABT
Abbott Laboratories
NYSE · Healthcare · Medical - Devices · US
$109.13
+0.31%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
18.8x
EV/EBITDA
21.8x
Market Cap
$188.84B
MomentumView details →
1D Return
+0.31%
YTD Return
−13.39%
RSI (14)
47.8
ValuationView details →
P/E (Fwd)
18.8x
EV/EBITDA
21.8x
Market Cap
$188.84B
RSI (14)
47.8
MomentumView details →
1D Return
+0.31%
YTD Return
−13.39%
SummaryUpdated Jun 1, 2026
Abbott Laboratories (NYSE:ABT) is a diversified healthcare company founded in 1888 and headquartered in North Chicago, Illinois. Originally established as a pharmaceutical company by Dr. Wallace Calvin Abbott, the company has evolved over more than 135 years into one of the world's largest healthcare corporations. Abbott operates across four major business segments: Medical Devices, Diagnostics, Nutritional Products, and Established Pharmaceutical Products, serving patients and healthcare providers in over 160 countries worldwide.
Similar companies
Latest newsMore news →
Abbott launched Similac 360 Total Care Made With Whole Milk, the first and only ready-to-feed liquid infant formula made with whole milk in the U.S., at a price similar to its existing Similac powdered formula, available online and at major U.S. retailers.4d agoChina's National Healthcare Security Administration held a symposium on August 27, 2026, with 16 pharmaceutical companies to discuss industry development and gather opinions for the 15th Five-Year Plan period.8d ago